{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T15:00:11Z","timestamp":1793890811865,"version":"4.8.0"},"reference-count":136,"publisher":"Oxford University Press (OUP)","issue":"suppl_3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8,15]]},"DOI":"10.1093\/infdis\/jix130","type":"journal-article","created":{"date-parts":[[2017,3,10]],"date-time":"2017-03-10T12:15:20Z","timestamp":1489148120000},"page":"S474-S483","source":"Crossref","is-referenced-by-count":155,"title":["Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi"],"prefix":"10.1093","volume":"216","author":[{"given":"Matthew W","family":"McCarthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P","family":"Kontoyiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver A","family":"Cornely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Perfect","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,9,5]]},"reference":[{"key":"key\n\t\t\t\t20170906122415_CIT0001","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/myc.12265","article-title":"Emerging drugs and vaccines for candidemia","volume":"57","year":"2014","journal-title":"Mycoses"},{"key":"key\n\t\t\t\t20170906122415_CIT0002","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1126\/science.aaa6097","article-title":"Infectious disease. How to bolster the antifungal pipeline","volume":"347","year":"2015","journal-title":"Science"},{"key":"key\n\t\t\t\t20170906122415_CIT0003","article-title":"Treatment principles for the management of mold infections","volume":"5","year":"2015","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key\n\t\t\t\t20170906122415_CIT0004","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrd3074","article-title":"An insight into the antifungal pipeline: selected new molecules and beyond","volume":"9","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170906122415_CIT0005","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1182\/blood-2011-03-316430","article-title":"How I treat mucormycosis","volume":"118","year":"2011","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170906122415_CIT0006","first-page":"11","article-title":"Emerging threats in antifungal-resistant fungal pathogens","volume":"3","year":"2016","journal-title":"Front Med (Lausanne)"},{"key":"key\n\t\t\t\t20170906122415_CIT0007","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/2047-783X-16-4-153","article-title":"Epidemiology and antifungal resistance in invasive aspergillosis according to primary disease: review of the literature","volume":"16","year":"2011","journal-title":"Eur J Med Res"},{"key":"key\n\t\t\t\t20170906122415_CIT0008","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/mmy\/myw060","article-title":"The anti-Aspergillus drug pipeline: is the glass half full or empty?","volume":"55","year":"2017","journal-title":"Med Mycol"},{"key":"key\n\t\t\t\t20170906122415_CIT0009","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nchembio.1205","article-title":"Systems-level antimicrobial drug and drug synergy discovery","volume":"9","year":"2013","journal-title":"Nat Chem Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0010","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0966-842X(00)88890-3","article-title":"The fungal cell wall as a drug target","volume":"3","year":"1995","journal-title":"Trends Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0011","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1046\/j.1365-2958.2003.03481.x","article-title":"Medicinal genetics approach towards identifying the molecular target of a novel inhibitor of fungal cell wall assembly","volume":"48","year":"2003","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0012","doi-asserted-by":"crossref","first-page":"23639","DOI":"10.1074\/jbc.M301044200","article-title":"GWT1 gene is required for inositol acylation of glycosylphosphatidylinositol anchors in yeast","volume":"278","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170906122415_CIT0013","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1128\/AAC.00731-11","article-title":"E1210, a new broad-spectrum antifungal, suppresses Candida albicans hyphal growth through inhibition of glycosylphosphatidylinositol biosynthesis","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0014","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1128\/AAC.00291-11","article-title":"In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0015","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1093\/jac\/dkr342","article-title":"Pre-clinical development of antifungal susceptibility test methods for the testing of the novel antifungal agent E1210 versus Candida: comparison of CLSI and European Committee on Antimicrobial Susceptibility Testing methods","volume":"66","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0016","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1128\/AAC.00366-11","article-title":"Efficacy of oral E1210, a new broad-spectrum antifungal with a novel mechanism of action, in murine models of candidiasis, aspergillosis, and fusariosis","volume":"55","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0017","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1021\/cb300235m","article-title":"Inhibiting GPI anchor biosynthesis in fungi stresses the endoplasmic reticulum and enhances immunogenicity","volume":"7","year":"2012","journal-title":"ACS Chem Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0018","doi-asserted-by":"crossref","first-page":"e1002870","DOI":"10.1371\/journal.ppat.1002870","article-title":"Antifungal drug discovery: something old and something new","volume":"8","year":"2012","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170906122415_CIT0019","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.6.1.1","article-title":"Compounds active against cell walls of medically important fungi","volume":"6","year":"1993","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170906122415_CIT0020","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/40.5.611","article-title":"Echinocandins and pneumocandins\u2014a new antifungal class with a novel mode of action","volume":"40","year":"1997","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0021","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(03)14472-8","article-title":"Echinocandin antifungal drugs","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170906122415_CIT0022","article-title":"Structure-activity relationships of a series of echinocandins and the discovery of CD101, a highly stable and soluble echinocandin with distinctive pharmacokinetic properties","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0023","doi-asserted-by":"crossref","first-page":"6872","DOI":"10.1128\/AAC.00701-16","article-title":"Preclinical evaluation of the stability, safety, and efficacy of CD101, a novel echinocandin","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0024","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1093\/jac\/dkw214","article-title":"Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0025","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/cmi.12640","article-title":"CD101: a novel long-acting echinocandin","volume":"18","year":"2016","journal-title":"Cell Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0026","doi-asserted-by":"crossref","first-page":"e01627-16","DOI":"10.1128\/AAC.01627-16","article-title":"Safety and pharmacokinetics of CD101 IV, a novel echinocandin, in healthy adults","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0027","article-title":"In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis","year":"2017","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0028","article-title":"New developments and directions in the clinical application of the echinocandins","year":"2017","journal-title":"Arch Toxicol"},{"key":"key\n\t\t\t\t20170906122415_CIT0029","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1128\/AAC.04445-14","article-title":"Pharmacodynamic target evaluation of a novel oral glucan synthase inhibitor, SCY-078 (MK-3118), using an in vivo murine invasive candidiasis model","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0030","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-4939-6515-1_5","article-title":"Systemic antifungal agents: current status and projected future developments","volume":"1508","year":"2017","journal-title":"Methods Mol Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0031","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1128\/AAC.00234-15","article-title":"Antifungal activities of SCY-078 (MK-3118) and standard antifungal agents against clinical non-Aspergillus mold isolates","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0032","first-page":"AAC.02068-16","article-title":"SCY-078 a first in class orally active antifungal glucan synthesis inhibitor: pre-clinical pharmacokinetics and pharmacodynamic target in murine models of disseminated candidiasis","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0033","doi-asserted-by":"crossref","first-page":"e01961-16","DOI":"10.1128\/AAC.01961-16","article-title":"SCY-078 is fungicidal in time-kill studies against Candida species","volume":"61","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0034","first-page":"55","article-title":"Chitin synthases in yeast and fungi","volume":"87","year":"1999","journal-title":"EXS"},{"key":"key\n\t\t\t\t20170906122415_CIT0035","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.fgb.2015.08.001","article-title":"Cell wall protection by the Candida albicans class I chitin synthases","volume":"82","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0036","doi-asserted-by":"crossref","first-page":"31427","DOI":"10.1074\/jbc.M112.352096","article-title":"Structural and functional characterization of NikO, an enolpyruvyl transferase essential in nikkomycin biosynthesis","volume":"287","year":"2012","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170906122415_CIT0037","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1128\/AAC.41.9.2026","article-title":"Efficacy of nikkomycin Z against experimental pulmonary blastomycosis","volume":"41","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0038","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1093\/infdis\/jiu029","article-title":"Modeling nikkomycin Z dosing and pharmacology in murine pulmonary coccidioidomycosis preparatory to phase 2 clinical trials","volume":"209","year":"2014","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170906122415_CIT0039","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1475-2859-13-59","article-title":"Novel nikkomycin analogues generated by mutasynthesis in streptomyces ansochromogenes","volume":"13","year":"2014","journal-title":"Microb Cell Fact"},{"key":"key\n\t\t\t\t20170906122415_CIT0040","article-title":"Glycosphingolipids of human embryonic stem cells","year":"2016","journal-title":"Glycoconj J"},{"key":"key\n\t\t\t\t20170906122415_CIT0041","first-page":"138","article-title":"Structural diversity and biological significance of glycosphingolipids in pathogenic and opportunistic fungi","volume":"4","year":"2014","journal-title":"Front Cell Infect Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0042","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-5793(02)03067-3","article-title":"Disruption of the glucosylceramide biosynthetic pathway in Aspergillus nidulans and Aspergillus fumigatus by inhibitors of UDP-Glc:ceramide glucosyltransferase strongly affects spore germination, cell cycle, and hyphal growth","volume":"525","year":"2002","journal-title":"FEBS Lett"},{"key":"key\n\t\t\t\t20170906122415_CIT0043"},{"key":"key\n\t\t\t\t20170906122415_CIT0044","first-page":"e00647","article-title":"Identification of a new class of antifungals targeting the synthesis of fungal sphingolipids","volume":"6","year":"2015","journal-title":"MBio"},{"key":"key\n\t\t\t\t20170906122415_CIT0045","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/EC.1.5.657-662.2002","article-title":"Life and death in a macrophage: role of the glyoxylate cycle in virulence","volume":"1","year":"2002","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0046","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1099\/mic.0.030858-0","article-title":"Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis","volume":"155","year":"2009","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20170906122415_CIT0047","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1099\/mic.0.2008\/020289-0","article-title":"The activity of the glyoxylate cycle in peroxisomes of Candida albicans depends on a functional beta-oxidation pathway: evidence for reduced metabolite transport across the peroxisomal membrane","volume":"154","year":"2008","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20170906122415_CIT0048","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.fgb.2006.01.015","article-title":"Analysis of the regulation, expression, and localisation of the isocitrate lyase from Aspergillus fumigatus, a potential target for antifungal drug development","volume":"43","year":"2006","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0049","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.bmcl.2009.01.017","article-title":"5-Hydroxyindole-type alkaloids, as Candida albicans isocitrate lyase inhibitors, from the tropical sponge Hyrtios sp","volume":"19","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170906122415_CIT0050","doi-asserted-by":"crossref","first-page":"e95951","DOI":"10.1371\/journal.pone.0095951","article-title":"Inhibitors of the glyoxylate cycle enzyme ICL1 in Candida albicans for potential use as antifungal agents","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170906122415_CIT0051","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1021\/ol5037248","article-title":"Mohangamides A and B, new dilactone-tethered pseudo-dimeric peptides inhibiting Candida albicans isocitrate lyase","volume":"17","year":"2015","journal-title":"Org Lett"},{"key":"key\n\t\t\t\t20170906122415_CIT0052","article-title":"F901318, a novel antifungal agent from the orotomide class: discovery and mechanism of action","volume-title":"Advances Against Aspergillosis","year":"2016"},{"key":"key\n\t\t\t\t20170906122415_CIT0053","article-title":"The efficacy of F901318 a novel antifungal drug in an animal model of aspergillosis","volume-title":"Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology","year":"2016"},{"key":"key\n\t\t\t\t20170906122415_CIT0054","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2174\/1389200023337054","article-title":"The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans","volume":"3","year":"2002","journal-title":"Curr Drug Metab"},{"key":"key\n\t\t\t\t20170906122415_CIT0055","doi-asserted-by":"crossref","first-page":"12911","DOI":"10.1021\/jp802087w","article-title":"How do azoles inhibit cytochrome P450 enzymes? A density functional study","volume":"112","year":"2008","journal-title":"J Phys Chem A"},{"key":"key\n\t\t\t\t20170906122415_CIT0056"},{"key":"key\n\t\t\t\t20170906122415_CIT0057","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1016\/j.bmcl.2014.05.068","article-title":"Design and optimization of highly-selective fungal CYP51 inhibitors","volume":"24","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170906122415_CIT0058","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.1128\/AAC.00593-15","article-title":"Evaluation of VT-1161 for treatment of coccidioidomycosis in murine infection models","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0059","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1128\/AAC.03707-14","article-title":"The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0060","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/AAC.02336-15","article-title":"In vitro activity of ASP2397 against Aspergillus isolates with or without acquired azole resistance mechanisms","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0061","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/AAC.05954-11","article-title":"T-2307 causes collapse of mitochondrial membrane potential in yeast","volume":"56","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0062","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1128\/AAC.01159-07","article-title":"In vitro and in vivo antifungal activities of T-2307, a novel arylamidine","volume":"52","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0063","doi-asserted-by":"crossref","first-page":"3630","DOI":"10.1128\/AAC.00355-10","article-title":"T-2307 shows efficacy in a murine model of Candida glabrata infection despite in vitro trailing growth phenomena","volume":"54","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0064","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1093\/jac\/dkv398","article-title":"The novel arylamidine T-2307 demonstrates in vitro and in vivo activity against echinocandin-resistant Candida glabrata","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0065","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1128\/AAC.00850-15","article-title":"Identification and characterization of a novel family of selective antifungal compounds (CANBEFs) that interfere with fungal protein synthesis","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0066","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1093\/jac\/dkv446","article-title":"Identification and characterization of haemofungin, a novel antifungal compound that inhibits the final step of haem biosynthesis","volume":"71","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0067","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/EC.05170-11","article-title":"Sampangine inhibits heme biosynthesis in both yeast and human","volume":"10","year":"2011","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0068","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1021\/acs.jnatprod.5b00819","article-title":"Sampangine (a copyrine alkaloid) exerts biological activities through cellular redox cycling of its quinone and semiquinone intermediates","volume":"78","year":"2015","journal-title":"J Nat Prod"},{"key":"key\n\t\t\t\t20170906122415_CIT0069","doi-asserted-by":"crossref","first-page":"14648","DOI":"10.1039\/C5CC05699C","article-title":"The discovery of novel antifungal scaffolds by structural simplification of the natural product sampangine","volume":"51","year":"2015","journal-title":"Chem Commun (Camb)"},{"key":"key\n\t\t\t\t20170906122415_CIT0070","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1128\/EC.05071-11","article-title":"Functional analyses of two acetyl coenzyme A synthetases in the ascomycete Gibberella zeae","volume":"10","year":"2011","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0071","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1021\/acsinfecdis.5b00134","article-title":"Antitumor\/antifungal celecoxib derivative AR-12 is a non-nucleoside inhibitor of the ANL-family adenylating enzyme acetyl CoA synthetase","volume":"2","year":"2016","journal-title":"ACS Infect Dis"},{"key":"key\n\t\t\t\t20170906122415_CIT0072","doi-asserted-by":"crossref","first-page":"7115","DOI":"10.1128\/AAC.01061-16","article-title":"The celecoxib derivative AR-12 has broad-spectrum antifungal activity in vitro and improves the activity of fluconazole in a murine model of cryptococcosis","volume":"60","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0073","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1158\/0008-5472.CAN-03-4063","article-title":"From the cyclooxygenase-2 inhibitor celecoxib to a novel class of 3-phosphoinositide-dependent protein kinase-1 inhibitors","volume":"64","year":"2004","journal-title":"Cancer Res"},{"key":"key\n\t\t\t\t20170906122415_CIT0074","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/MMBR.64.4.746-785.2000","article-title":"Signal transduction cascades regulating fungal development and virulence","volume":"64","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"key":"key\n\t\t\t\t20170906122415_CIT0075","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1567-1364.2009.00545.x","article-title":"The Cek1 MAPK is a short-lived protein regulated by quorum sensing in the fungal pathogen Candida albicans","volume":"9","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"key\n\t\t\t\t20170906122415_CIT0076","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1128\/EC.00218-13","article-title":"Stress signaling pathways for the pathogenicity of Cryptococcus","volume":"12","year":"2013","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0077","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.fgb.2012.11.001","article-title":"The transmembrane protein Opy2 mediates activation of the Cek1 MAP kinase in Candida albicans","volume":"50","year":"2013","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0078","doi-asserted-by":"crossref","first-page":"e1001069","DOI":"10.1371\/journal.ppat.1001069","article-title":"PKC signaling regulates drug resistance of the fungal pathogen Candida albicans via circuitry comprised of Mkc1, calcineurin, and Hsp90","volume":"6","year":"2010","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170906122415_CIT0079","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1128\/EC.00133-10","article-title":"Interaction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human beta-defensins 2 and 3","volume":"10","year":"2011","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0080","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/MCB.24.8.3307-3323.2004","article-title":"Evidence of a new role for the high-osmolarity glycerol mitogen-activated protein kinase pathway in yeast: regulating adaptation to citric acid stress","volume":"24","year":"2004","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0081","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1128\/EC.1.2.163-173.2002","article-title":"Heat stress activates the yeast high-osmolarity glycerol mitogen-activated protein kinase pathway, and protein tyrosine phosphatases are essential under heat stress","volume":"1","year":"2002","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0082","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1128\/JB.181.10.3058-3068.1999","article-title":"Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans","volume":"181","year":"1999","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20170906122415_CIT0083","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12864-015-1879-4","article-title":"Genomic profiling of fungal cell wall-interfering compounds: identification of a common gene signature","volume":"16","year":"2015","journal-title":"BMC Genomics"},{"key":"key\n\t\t\t\t20170906122415_CIT0084","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00792-013-0546-4","article-title":"The HOG signal transduction pathway in the halophilic fungus Wallemia ichthyophaga: identification and characterisation of MAP kinases WiHog1A and WiHog1B","volume":"17","year":"2013","journal-title":"Extremophiles"},{"key":"key\n\t\t\t\t20170906122415_CIT0085","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.1128\/IAI.00834-08","article-title":"Two-component signal transduction proteins as potential drug targets in medically important fungi","volume":"76","year":"2008","journal-title":"Infect Immun"},{"key":"key\n\t\t\t\t20170906122415_CIT0086","doi-asserted-by":"crossref","first-page":"e20012","DOI":"10.1371\/journal.pone.0020012","article-title":"Design, synthesis, and characterization of a highly effective Hog1 inhibitor: a powerful tool for analyzing MAP kinase signaling in yeast","volume":"6","year":"2011","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170906122415_CIT0087","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/mic.0.28571-0","article-title":"Calcineurin, Mpk1 and Hog1 MAPK pathways independently control fludioxonil antifungal sensitivity in Cryptococcus neoformans","volume":"152","year":"2006","journal-title":"Microbiology"},{"key":"key\n\t\t\t\t20170906122415_CIT0088","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.7164\/antibiotics.53.1182","article-title":"On the mechanism of action of the myxobacterial fungicide ambruticin","volume":"53","year":"2000","journal-title":"J Antibiot (Tokyo)"},{"key":"key\n\t\t\t\t20170906122415_CIT0089","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1378\/chest.73.2.202","article-title":"Therapeutic properties of oral ambruticin (W7783) in experimental pulmonary coccidioidomycosis of mice","volume":"73","year":"1978","journal-title":"Chest"},{"key":"key\n\t\t\t\t20170906122415_CIT0090","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1128\/AAC.00670-06","article-title":"Efficacy of ambruticin analogs in a murine model of coccidioidomycosis","volume":"50","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0091","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1021\/cb100399x","article-title":"Identification, in vitro activity and mode of action of phosphoinositide-dependent-1 kinase inhibitors as antifungal molecules","volume":"6","year":"2011","journal-title":"ACS Chem Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0092","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1002\/jcp.24977","article-title":"OSU-03012 and Viagra treatment inhibits the activity of multiple chaperone proteins and disrupts the blood-brain barrier: implications for anti-cancer therapies","volume":"230","year":"2015","journal-title":"J Cell Physiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0093","first-page":"726","article-title":"Effect of CCH1 or MID1 gene disruption on drug tolerance and pathogenesis of Candida albicans","volume":"28","year":"2012","journal-title":"Sheng Wu Gong Cheng Xue Bao"},{"key":"key\n\t\t\t\t20170906122415_CIT0094","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11046-014-9735-7","article-title":"The calcium channel blocker verapamil inhibits oxidative stress response in Candida albicans","volume":"177","year":"2014","journal-title":"Mycopathologia"},{"key":"key\n\t\t\t\t20170906122415_CIT0095","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1111\/j.1365-2958.2008.06242.x","article-title":"Systematic functional analysis of calcium-signalling proteins in the genome of the rice-blast fungus, Magnaporthe oryzae, using a high-throughput RNA-silencing system","volume":"68","year":"2008","journal-title":"Mol Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0096","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1128\/EC.00038-14","article-title":"Calcineurin-Crz1 signaling in lower eukaryotes","volume":"13","year":"2014","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0097","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nrmicro1680","article-title":"Harnessing calcineurin as a novel anti-infective agent against invasive fungal infections","volume":"5","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0098","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1128\/EC.00145-06","article-title":"Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans","volume":"5","year":"2006","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0099","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1111\/j.1462-5822.2008.01198.x","article-title":"Candida albicans transcription factor Rim101 mediates pathogenic interactions through cell wall functions","volume":"10","year":"2008","journal-title":"Cell Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0100","doi-asserted-by":"crossref","first-page":"5885","DOI":"10.1128\/AAC.00726-15","article-title":"Potential targets for antifungal drug discovery based on growth and virulence in Candida albicans","volume":"59","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0101","doi-asserted-by":"crossref","first-page":"36720","DOI":"10.1074\/jbc.M406179200","article-title":"Genetic, biochemical, and transcriptional responses of Saccharomyces cerevisiae to the novel immunomodulator FTY720 largely mimic those of the natural sphingolipid phytosphingosine","volume":"279","year":"2004","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170906122415_CIT0102","doi-asserted-by":"crossref","first-page":"e81907","DOI":"10.1371\/journal.pone.0081907","article-title":"Fingolimod (FTY720) stimulates Ca(2+)\/calcineurin signaling in fission yeast","volume":"8","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20170906122415_CIT0103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/1471-2180-11-209","article-title":"The Aspergillus giganteus antifungal protein AFPNN5353 activates the cell wall integrity pathway and perturbs calcium homeostasis","volume":"11","year":"2011","journal-title":"BMC Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0104","doi-asserted-by":"crossref","first-page":"13859","DOI":"10.1074\/jbc.M110.203588","article-title":"Survival strategies of yeast and filamentous fungi against the antifungal protein AFP","volume":"286","year":"2011","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170906122415_CIT0105","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/j.fgb.2008.07.019","article-title":"A comparative genomic analysis of calcium and proton signaling\/homeostasis in Aspergillus species","volume":"46","year":"2009","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0106","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.fgb.2004.05.001","article-title":"A comparative genomic analysis of the calcium signaling machinery in Neurospora crassa, Magnaporthe grisea, and Saccharomyces cerevisiae","volume":"41","year":"2004","journal-title":"Fungal Genet Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0107","doi-asserted-by":"crossref","first-page":"e1004936","DOI":"10.1371\/journal.ppat.1004936","article-title":"Exploiting fungal virulence-regulating transcription factors as novel antifungal drug targets","volume":"11","year":"2015","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170906122415_CIT0108","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/tpj.12217","article-title":"Fungal-specific transcription factor AbPf2 activates pathogenicity in Alternaria brassicicola","volume":"75","year":"2013","journal-title":"Plant J"},{"key":"key\n\t\t\t\t20170906122415_CIT0109","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2011.10.048","article-title":"A recently evolved transcriptional network controls biofilm development in Candida albicans","volume":"148","year":"2012","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/EC.3.2.546-552.2004","article-title":"Inactivation of transcription factor gene ACE2 in the fungal pathogen Candida glabrata results in hypervirulence","volume":"3","year":"2004","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0111","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nrd2132","article-title":"Drugs, their targets and the nature and number of drug targets","volume":"5","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"key\n\t\t\t\t20170906122415_CIT0112","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cbpa.2005.08.012","article-title":"Chemical approaches to transcriptional regulation","volume":"9","year":"2005","journal-title":"Curr Opin Chem Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0113","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.cbpa.2010.03.022","article-title":"A complex task? Direct modulation of transcription factors with small molecules","volume":"14","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0114","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1074\/jbc.R109.075044","article-title":"Transcriptional switches: chemical approaches to gene regulation","volume":"285","year":"2010","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170906122415_CIT0115","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/AAC.01677-13","article-title":"Novel antifungal drug discovery based on targeting pathways regulating the fungus-conserved Upc2 transcription factor","volume":"58","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0116","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1128\/AAC.49.5.1745-1752.2005","article-title":"Candida albicans zinc cluster protein Upc2p confers resistance to antifungal drugs and is an activator of ergosterol biosynthetic genes","volume":"49","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170906122415_CIT0117","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1128\/EC.00245-13","article-title":"Distinct roles of Candida albicans drug resistance transcription factors TAC1, MRR1, and UPC2 in virulence","volume":"13","year":"2014","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0118","first-page":"e00637","article-title":"Regulatory role of glycerol in Candida albicans biofilm formation","volume":"4","year":"2013","journal-title":"MBio"},{"key":"key\n\t\t\t\t20170906122415_CIT0119","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1128\/EC.00103-12","article-title":"Divergent targets of Candida albicans biofilm regulator Bcr1 in vitro and in vivo","volume":"11","year":"2012","journal-title":"Eukaryot Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0120","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1371\/journal.ppat.0020063","article-title":"Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo","volume":"2","year":"2006","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20170906122415_CIT0121","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/ng.605","article-title":"Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity","volume":"42","year":"2010","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20170906122415_CIT0122","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.cell.2008.07.046","article-title":"Systematic genetic analysis of virulence in the human fungal pathogen Cryptococcus neoformans","volume":"135","year":"2008","journal-title":"Cell"},{"key":"key\n\t\t\t\t20170906122415_CIT0123","doi-asserted-by":"crossref","first-page":"6757","DOI":"10.1038\/ncomms7757","article-title":"Systematic functional profiling of transcription factor networks in Cryptococcus neoformans","volume":"6","year":"2015","journal-title":"Nat Commun"},{"key":"key\n\t\t\t\t20170906122415_CIT0124","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1101\/gr.184101.114","article-title":"Model-driven mapping of transcriptional networks reveals the circuitry and dynamics of virulence regulation","volume":"25","year":"2015","journal-title":"Genome Res"},{"key":"key\n\t\t\t\t20170906122415_CIT0125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI69738","article-title":"New and emerging HDAC inhibitors for cancer treatment","volume":"124","year":"2014","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20170906122415_CIT0126","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1128\/JCM.00618-09","article-title":"Activity of MGCD290, a Hos2 histone deacetylase inhibitor, in combination with azole antifungals against opportunistic fungal pathogens","volume":"47","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0127","doi-asserted-by":"crossref","first-page":"307","DOI":"10.2217\/epi.10.7","article-title":"Small-molecule chromatin-modifying agents: therapeutic applications","volume":"2","year":"2010","journal-title":"Epigenomics"},{"key":"key\n\t\t\t\t20170906122415_CIT0128","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.diagmicrobio.2014.11.008","article-title":"In vitro activity of a Hos2 deacetylase inhibitor, MGCD290, in combination with echinocandins against echinocandin-resistant Candida species","volume":"81","year":"2015","journal-title":"Diagn Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20170906122415_CIT0129","first-page":"96","article-title":"Histone deacetylase inhibition as an alternative strategy against invasive aspergillosis","volume":"6","year":"2015","journal-title":"Front Microbiol"},{"key":"key\n\t\t\t\t20170906122415_CIT0130","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1080\/10428194.2016.1204652","article-title":"Epidemiology of invasive fungal infections during induction therapy in adults with acute lymphoblastic leukemia: a GRAALL-2005 study","volume":"58","year":"2017","journal-title":"Leuk Lymphoma"},{"key":"key\n\t\t\t\t20170906122415_CIT0131","first-page":"30","article-title":"International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus","volume":"21\u201322","year":"2015","journal-title":"Drug Resist Updat"},{"key":"key\n\t\t\t\t20170906122415_CIT0132","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jcf.2016.06.006","article-title":"Triazole resistance in Aspergillus fumigatus isolates from patients with cystic fibrosis in Italy","volume":"16","year":"2017","journal-title":"J Cyst Fibros"},{"key":"key\n\t\t\t\t20170906122415_CIT0133","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","year":"2005","journal-title":"Blood"},{"key":"key\n\t\t\t\t20170906122415_CIT0134","doi-asserted-by":"crossref","first-page":"10660","DOI":"10.1073\/pnas.1312789111","article-title":"Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection","volume":"111","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170906122415_CIT0135","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.chembiol.2011.01.009","article-title":"Confronting the challenges of natural product-based antifungal discovery","volume":"18","year":"2011","journal-title":"Chem Biol"},{"key":"key\n\t\t\t\t20170906122415_CIT0136","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S1473-3099(12)70293-1","article-title":"A comprehensive regulatory framework to address the unmet need for new antibacterial treatments","volume":"13","year":"2013","journal-title":"Lancet Infect Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/216\/suppl_3\/S474\/19708761\/jix130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T21:55:04Z","timestamp":1658786104000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jid\/article\/216\/suppl_3\/S474\/4107051\/Novel-Agents-and-Drug-Targets-to-Meet-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,15]]},"references-count":136,"journal-issue":{"issue":"suppl_3","published-online":{"date-parts":[[2017,9,5]]},"published-print":{"date-parts":[[2017,8,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jix130","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,15]]}}}